|
ACIN1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.822500E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.397000E-03 |
| Normal-vs-Stage2 |
2.327400E-01 |
| Normal-vs-Stage3 |
2.251400E-01 |
| Normal-vs-Stage4 |
9.241600E-01 |
| Stage1-vs-Stage2 |
5.234000E-01 |
| Stage1-vs-Stage3 |
4.066800E-01 |
| Stage1-vs-Stage4 |
2.341800E-01 |
| Stage2-vs-Stage3 |
9.406000E-01 |
| Stage2-vs-Stage4 |
4.579600E-01 |
| Stage3-vs-Stage4 |
4.615000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.152600E-04 |
| Normal-vs-AfricanAmerican |
6.102500E-02 |
| Normal-vs-Asian |
1.651380E-01 |
| Caucasian-vs-AfricanAmerican |
1.867450E-01 |
| Caucasian-vs-Asian |
2.136400E-01 |
| AfricanAmerican-vs-Asian |
2.965200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.382800E-04 |
| Normal-vs-Female |
1.154190E-02 |
| Male-vs-Female |
5.847200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.301600E-02 |
| Normal-vs-Extreme_Weight |
1.054440E-02 |
| Normal-vs-Obese |
1.486380E-02 |
| Normal-vs-Extreme_Obese |
1.173230E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.641400E-01 |
| Normal_Weight-vs-Obese |
8.598600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.264800E-01 |
| Extreme_Weight-vs-Obese |
8.808600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.404800E-01 |
| Obese-vs-Extreme_Obese |
8.832200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.698000E-02 |
| Normal-vs-Age(41-60Yrs) |
9.60479999999597E-05 |
| Normal-vs-Age(61-80Yrs) |
3.804700E-03 |
| Normal-vs-Age(81-100Yrs) |
5.919000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.185800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.013800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.940300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.232000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.069540E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.309800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.59489999990359E-07 |
| Normal-VS-Type2 PRCC |
3.446800E-01 |
| Normal-VS-KIRP CIMP |
5.388600E-01 |
| Normal-VS-Unclassified PRCC |
5.617600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.10730322081076E-11 |
| Type1 PRCC-VS-KIRP CIMP |
3.524700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.976300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.445600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.537600E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.114780E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.390620E-01 |
| Normal-vs-N1 |
1.734110E-02 |
| Normal-vs-N2 |
7.555900E-02 |
| N0-vs-N1 |
4.908800E-01 |
| N0-vs-N2 |
1.264840E-01 |
| N1-vs-N2 |
1.767970E-02 |
|
|
